Esca (grape disease)
Esca is a complex grapevine disease affecting vineyards worldwide, characterized by symptoms that include leaf discoloration, known as "tiger-stripes," and the appearance of a white rot in the wood, leading to reduced grape yield and quality. This disease is caused by a consortium of fungi, including Phaeomoniella chlamydospora and species of Phaeoacremonium, among others. Esca has been a known issue in viticulture for centuries, with occurrences reported as far back as the Roman times. The disease cycle and its management are critical areas of study in plant pathology and viticulture to mitigate its impact on wine production.
Symptoms and Diagnosis[edit | edit source]
Esca presents a variety of symptoms that can affect all parts of the grapevine. Early signs include the yellowing and wilting of leaves, which may display distinct patterns of necrosis. As the disease progresses, the vine's vascular system is compromised, leading to stunted growth and, eventually, the death of the vine. The most characteristic symptom is the appearance of a white rot within the wood, accompanied by black, tar-like streaks. Diagnosis of Esca is primarily based on these visual symptoms, supported by laboratory analysis to identify the specific fungi involved.
Causative Agents[edit | edit source]
The disease is polyphyletic, caused by a combination of fungal species. Phaeomoniella chlamydospora and various Phaeoacremonium spp. are among the primary fungi associated with Esca. These fungi colonize the xylem tissues of the grapevine, obstructing water and nutrient flow and secreting toxic compounds that contribute to the disease symptoms. The complex nature of its etiology makes Esca particularly challenging to manage and control.
Disease Cycle[edit | edit source]
The disease cycle of Esca involves the colonization of the grapevine's wood tissues by the causative fungi. These organisms can enter the vine through pruning wounds or other mechanical damages, where they establish and proliferate. The fungi can remain latent within the plant for several years before symptoms become apparent, complicating early detection and management efforts.
Management and Control[edit | edit source]
Effective management of Esca is challenging due to its complex etiology and the latency period of the disease. Current strategies focus on preventive measures, including the use of resistant grapevine cultivars, proper pruning techniques to minimize wound size, and the application of fungicides or biological control agents to pruning wounds. However, these methods offer limited effectiveness, and there is ongoing research into more sustainable and effective control measures.
Impact on Viticulture[edit | edit source]
Esca significantly impacts viticulture, leading to losses in both yield and grape quality. Affected vineyards may experience a decline in productivity over time, with severe cases resulting in the death of vines and the need for replanting. The economic implications of the disease are considerable, necessitating ongoing research and development of more effective management strategies.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD